Topic: Eli Lilly

Another diabetes drug maker is taking legal action against businesses in several states, alleging that they're "fraudulently claiming" that their compounded products are the same as its medication.

A Louisiana woman is suing the makers of Ozempic and Mounjaro, accusing the pharmaceuticals of failing to warn her and other patients of the risk of severe stomach issues associated with their diabetic drugs.

People living with the pain, bloody diarrhea and sometimes urgent need to use the toilet that comes with ulcerative colitis may soon have a new treatment option that's already been given the go-ahead in Europe.

Another experimental drug meant to slow the damage of Alzheimer's appears poised to join a growing arsenal of new treatments for this memory-robbing disease.

Eli Lilly announced Friday a $1.93 billion cash deal to buy Versanis, a private clinical-stage biopharmaceutical company focused on weight-loss drugs.

Over the past weekend the results of multiple clinical trials from would-be competitors to Ozempic and Wegovy for weight loss were unveiled at this year's annual meeting of the American Diabetes Association (ADA).

Drugmaker Eli Lilly said Tuesday that it had agreed to a $2.4 billion deal to acquire Dice Therapeutics, a company that develops drugs for autoimmune diseases.

Danish drugmaker Novo Nordisk said it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.

Pharmaceutical giant Eli Lilly said Wednesday results from a Phase 3 study on its Alzheimer's treatment show it slowed clinical cognitive and functional decline by 35% compared with a placebo.

Sen. Bernie Sanders announced Friday that CEOs from the major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi will testify at a hearing next month.